President Donald Trump’s administration pressed forward with plans to impose tariffs on semiconductor and pharmaceutical ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Chief Financial Officer Jurriaan Dekkers and Chief Corporate Development Officer René Beukema will be stepping down from their roles, having played key roles in supporting the Company’s strategic ...

Healthcare stocks ended a volatile Wall Street week on a positive note. Explore top movers, Novartis' $23B U.S.

WHO is nearing a treaty for future pandemics, Novartis invests $23 billion in the US amidst drug tariff threats, and measles ...

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.

Two days after pharma companies sounded an alarm that their investments were headed out of Europe, Novartis AG has announced ...

Novartis plans to invest $23 billion over the next five years to expand its manufacturing and research in the U.S. The investment will cover more than 10 facilities, including seven new sites, and ...

Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...